Healthcare -
Biotechnology - NASDAQ - US
$ 4.465
-1.22 %
$ 399 M
Market Cap
-10.15
P/E
TRVI - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities TRVI - Trevi Therapeutics, Inc.
59.4 M
LAST VALUE
0.00%
2 YEAR CAGR
227.74%
5 YEAR CAGR
0.00%
10 YEAR CAGR